A recent in vivo study in BLT2-deficient mice indicates that BLT2 protects against allergic airway inflammation and that reduced expression of BLT2 by CD4+ T cells might contribute to the pathophysiology of asthma [52]. This evidence concerns the gene LTB4R2 and asthma.